ecancermedicalscience

Erratum

Erratum: RENATA study—Latin American prospective experience: clinical outcome of patients treated with palbociclib in hormone receptor-positive metastatic breast cancer—real-world use

7 Aug 2020
Fernando Petracci, Gonzalo Gomez Abuin, Alejandra Pini, Matías Chacón

On page 3, the number 72.5 in the following sentence replaces the number 37.5 which was incorrect:

'The Overall CB was 82.5%, higher in first line than in second line, 85.9% and 62.5%, respectively. The ORR in first line were: 4.7% CR, 40.6% PR and 40.6% SD. In second line the ORR were: 25% PR, 37.5% SD and no CR.'

Related Articles

Hafssa El Hilali, Nassiba Bahra, Sanae Guennouni, Chaymae Chbihi, Samia El Hakym, Diango Keita, Sara Nejjari, Abir Oufrid, Oumaima Siyouri, Lamiae Amaadour, Karima Oualla, Zineb Benbrahim, Touria Bouhafa, Nawfel Mellas, Samira El Fakir, Samia Arifi
Bincy Mathew, Nitin Yashas Murthy, Amit Rauthan, Poonam Patil, Devesh Ballal, Shabber S Zaveri, Guddahatty Nanjappa Hemanth, Ananthakrishnan Nidheesh, Nidudi Javaregowda Harshitha
Hugo Castro-Salguero, Bremilin Ramírez-Najarro, Jorge Tello-Mérida, Lourdes Castro-Salazar, Luis García-Aceituno
Brindha Senthil Kumar, Ponnagoundanpudur Sundaramoorthy Kirit, Nachimuthu Senthil Kumar, Shanmuganandam Sumathi, Samuel Lalhruaizela, Lal Hruaitluanga, Lal Hmingliana